483 Shire Human Genetic Therapies Aug 2012

483 Shire Human Genetic Therapies Aug 2012

Debra Emerson FDA, Mary-Jeanet Mcgarry FDA$119.00 - Available Now

FDA investigators audited the Shire Human Genetic Therapies - Lexington, MA, United States facility and issued inspectional observations (via FDA 483) on 31 Aug 2012.

Product details

  • Category: Human Drugs
  • Inspection end: 31 Aug 2012
  • Location: Lexington, United States
  • FEI: 3009430815
Add To Cart